Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis

International Journal of Molecular Sciences

Volumn 13, Issue 8, 2012, Pages 10647-10659

  Patel, Jilpa ^a   Balabanov, Roumen ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Caspase 1; Cell signaling; Interferon regulatory factor 1; Multiple sclerosis; Oligodendrocytes; Pathology

Indexed keywords

GAMMA INTERFERON;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL DAMAGE; CELL DEATH; CELL PROTECTION; DEMYELINATION; HUMAN; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENIC MOUSE; ANIMAL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INFLAMMATION; PATHOLOGY;

ANIMALIA;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS; OLIGODENDROGLIA;

EID: 84871844210     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms130810647     Document Type: Review

References (69)

1. Noseworthy, J.; Lucchinetti, C.; Rodriguez, M.; Weinshenker, B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343, 938-952.
2. Hafler, D.A. Multiple sclerosis. J. Clin. Invest. 2004, 113, 788-794.
3. Lassmann, H. Multiple sclerosis pathology: Evaluation of pathogenic concepts. Brain Pathol. 2005, 15, 217-222.
4. Lucchinetti, C.; Brück, W.; Parisi, J.; Scheitauer, B.; Rodriguez, M.; Lassmann, H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47, 707-717.
5. Swanborg, R. Experimental allergic encephalomyelitis. Methods Enzymol. 1988, 162, 413-421.
6. Wingerchuk, D.M. Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking. Mt. Sinai J. Med. 2011, 78, 221-230.
7. International Multiple Sclerosis Genetics Consortium (MSGC). Refining genetic associations in multiple sclerosis. Lancet Neurol. 2008, 7, 567-569.
8. Willer, C.J.; Dyment, D.A.; Risch, N.J.; Sadovnick, A.D.; Ebers, G.C.; Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Natl. Acad. Sci. USA 2003, 100, 12877-12882.
9. Raine, C.S. Oligodendrocytes and Central Nervous System Myelin. In Textbook of Neuropathology, 2nd ed.; Davis, R.L., Robertson, D.M., Eds.; Williams and Wilkins: Baltimore, MD, USA, 1991; pp. 115-141.
10. Hartline, D.K.; Colman, D.R. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr. Biol. 2007, 17, R29-R35.
11. McTigue, D.M.; Tripathi, R.B. The life, death and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 2008, 107, 1-19.
12. Brady, S.T.; Witt, A.S.; Kirkpatrick, L.L.; de Waegh, S.M.; Readhead, C.; Tu, P.-H.; Lee, V.M.-Y. Formation of compact myelin is required for maturation of the axonal cytoskeleton. J. Neurosci. 1999, 19, 7278-7288.
13. Smith, K.; McDonald, W. The pathophysiology of multiple sclerosis: The mechanisms underlying the production of symptoms and the natural history of the disease. Phil. Trans. R. Soc. Lond. B 1999, 354, 1649-1673.
14. Trapp, B.D.; Peterson, J.; Ransohoff, M.M.; Rudick, R.; Mörk, S.; Bö, L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338, 278-285.
15. Waxman, S.G. Acquired channelopathies in nerve injury and MS. Neurology 2001, 56, 1621-1627.
16. Barnett, M.H.; Prineas, J.W. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann. Neurol. 2004, 55, 458-468.
17. Rodriguez, M.; Scheithauer, B.W.; Forbes, G.; Kelly, P.J. Oligodendrocyte injury is an early event in multiple scleosis. Mayo Clin. Proc. 1993, 68, 627-636.
18. Hisahara, S.; Araki, T.; Sugiyama, F.; Yagami, K.; Suzuki, M.; Abe, K.; Yamamura, K.; Miyazaki, J.; Momoi, T.; Satura, T.; et al. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J. 2000, 19, 341-348.
19. Hovelmeyer, N.; Hao, Z.; Kranidioti, K.; Kassiotis, G.; Buch, T.; Frommer, F.; von Hoch, L.; Kramer, D.; Minichiello, L.; Kollias, G.; et al. Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 2005, 175, 5875-5884.
20. Balabanov, R.; Strand, K.; Goswami, R.; McMahon, E.; Begolka, W.; Miller, S.D.; Popko, B. Interferon-γ-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J. Neurosci. 2007, 27, 2013-2024.
21. McGuire, C.; Volckaert, T.; Wolke, U.; Sze, M.; de Rycke, R.; Waisman, A.; Prinz, M.; Beyaert, R.; Rasparakis, M.; van Loo, G. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination. J. Immunol. 2010, 185, 7646-7653.
22. Ren, Z.; Wang, Y.; Tao, D.; Liebenson, D.; Liggett, T.; Goswami, R.; Stefoski, D.; Balabanov, R. Overexpression of the dominant negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis. J. Neurosci. 2011, 83, 8329-8341.
23. Mi, S.; Hu, B.; Hahm, K.; Luo, Y.; Hui, E.S.K.; Yuan, Q.; Wong, W.; Wang, L.; Su, H.; Chu, T.; et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat. Med. 2005, 13, 1228-1233.
24. Butzkueven, H.; Zhang, J.-G.; Soilu-Hanninen, M.; Hochrein, H.; Chionh, F.; Shipham, K.A.; Emery, B.; Turnley, A.M.; Petratos, S.; Ernst, M.; et al. LIF receptor signaling limits immune mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 2002, 8, 613-619.
25. Linker, R.; Maüer, M.; Gaupp, S.; Martini, R.; Holtmann, L.; Giess, R.; Rieckmann, P.; Lassmann, H.; Toyka, K.; Sendtner, M.; et al. CNTF is a major protective factor in demyelinating CNS disease: A neuroprotective cytokine as modulator in neuroinflammation. Nat. Med. 2002, 8, 620-624.
26. Steinmann, L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 1996, 185, 299-302.
27. Franklin, R.J.M. Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 2002, 3, 705-714.
28. Babbe, H.; Roers, A.; Waisman, A.; Lassmann, H.; Goebels, N.; Hohlfeld, R.; Friese, M.; Schröder, R.; Deckert, M.; Schmidt, S.; et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000, 192, 393-404.
29. Neumann, H.; Medana, I.M.; Bauer, J.; Lassmann, H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 2002, 25, 313-319.
30. Höftberger, R.; Aboul-Enein, F.; Brueck, W.; Lucchinetti, C.; Rodriguez, M.; Schmidbauer, M.; Jellinger, K.; Lassmann, H. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 2004, 14, 43-50.
31. Dowling, P.; Shang, G.; Raval, S.; Menonna, J.; Cook, S.; Husar, W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 1996, 184, 1513-1518.
32. Selmaj, K.; Raine, C. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 1988, 23, 339-346.
33. Vartanian, T.; Li, Y.; Zhao, M.; Stefansson, K. Interferon-γ induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol. Med. 1995, 1, 732-743.
34. Pouly, S.; Belcher, B.; Blain, M.; Antel, J.P. Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated injury. J. Neuropathol. Exp. Neurol. 2000, 59, 280-286.
35. Aquino, D.A.; Selmaj, K. Heat-shock proteins and gamma-delta T cell responses in the central nervous system. Chem. Immunol. 1992, 53, 86-101.
36. Van Noort, J.M.; van Sechel, A.C.; Bajramovic, J.J.; el Ouagmiri, M.; Polman, C.H.; Lassmann, H.; Ravid, R. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995, 375, 798-801.
37. Genain, C.P.; Cannella, B.; Hauser, S.L.; Raine, C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 1999, 5, 170-175.
38. Dubois-Dalcq, M.; Niedieck, B.; Buyse, M. Action of anti-cerebroside sera on myelinated nervous tissue cultures. Pathol. Eur. 1970, 5, 331-347.
39. Schenck, M.; Carpinteiro, A.; Grassme, H.; Lang, F.; Gulbins, E. Ceramide: Physiological and pathophysiological aspects. Arch. Biochem. Biophys. 2007, 462, 171-175.
40. Thorburne, S.K.; Juurlink, B.H. Low glutathione and high iron govern the susceptibility of oligodendrocyte precursors to oxidative stress. J. Neurochem. 1996, 67, 1014-1022.
41. Lin, W.; Kemper, A.; Dupree, J.L.; Harding, H.P.; Ron, D.; Popko B. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 2006, 129, 1306-1318.
42. McDonald, J.W.; Althomsons, S.P.; Hyrc, K.L.; Choi, D.W.; Goldberg, M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainite receptor-mediated cytotoxicity. Nat. Med. 1998, 4, 291-297.
43. Matute, C.; Torre, I.; Pérez-Gerdá, F.; Pérez-Samartín, A.; Alberdi, E.; Etxerbaria, E.; Arranz, A.M.; Ravid, R.; Rodriguez-Antigüedad, A.; Sánchez-Gómez, M.; et al. P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorate experimental autoimmune encephalomyelitis. J. Neurosci. 2007, 27, 9525-9533.
44. Singh, I.; Pahan, K.; Khan, M.; Singh, A.K. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine mediated apoptosis in demyelinating diseases. J. Biol. Chem. 1998, 273, 20354-20362.
45. Boullerne, A.I.; Rodriguez, J.J.; Touil, T.; Brochet, B.; Schmidt, S.; Abrous, N.D.; Le Moal, M.; Pua, J.R.; Jensen, M.A.; Mayo, W.; et al. Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: Implications for multiple sclerosis. J. Neurosci. 2002, 22, 123-132.
46. Lucchinetti, C.; Brück, W.; Parisi, J.; Scheithauer, B.; Rodriguez, M.; Lassmann, H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999, 122, 2279-2295.
47. Keirstead, K.S.; Blakemore, W.F. Identification of post-mitotic oligodendrocytes incapable of remyelination within demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 1997, 56, 1191-1201.
48. Wolswijk, G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002, 125, 338-349.
49. Baerwald, K.D.; Popko, B. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J. Neurosci. Res. 1998, 52, 230-239.
50. Bernardo, A.; Greco, A.; Levi, G.; Minghetti, L. Differential lipid peroxidation, Mn superoxide, and bcl-2 expression contribute to the maturation-dependent vulnerability of oligodendrocytes to oxidative stress. J. Neuropathol. Exp. Neurol. 2003, 62, 509-519.
51. Patrikios, P.; Stadelmann, C.; Kutzelnigg, A.; Rauschka, H.; Schmidbauer, M.; Laursen, H.; Sorensen, P.S.; Brück, W.; Lucchinetti, C.; Lassmann, H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129, 3165-3172.
52. Wolswijk, G. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 2000, 123, 105-115.
53. Ludwin, S.K.; Maitland, M. Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths. J. Neurol. Sci. 1984, 64, 193-198.
54. Bramow, S.; Frischer, J.M.; Lassmann, H.; Koch-Henriksen, N.; Lucchinetti, C.F.; Sørensen, P.S.; Laursen, H. Demyelination versus remyelination in progressive multiple sclerosis. Brain 2010, 133, 2983-2998.
55. Rodriguez, M.; Scheithauer, B. Ultrasctucture od multiple sclerosis. Ultratruct. Pathol. 1994, 18, 3-13.
56. Aboul-Enein, F.; Rauschka, H.; Kornek, B.; Stadelmann, C.; Stefferl, A.; Brück, W.; Lucchinetti, C.; Schmidbauer, M.; Jellinger, K.; Lassmann, H. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J. Neuropathol. Exp. Neurol. 2003, 62, 25-33.
57. Bo, L.; Vedeler, C.A.; Nyland, H.I.; Trapp, B.D.; Mork, S.J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 2003, 62, 723-732.
58. Serafini, B.; Rosicarelli, B.; Magliozzi, R.; Stigliano, E.; Aloisi, F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14, 164-174.
59. Magliozzi, R.; Howell, O.W.; Reeves, C.; Roncaroli, F.; Nicholas, R.; Serafini, B.; Aloisi, F.; Reynolds, R.A. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann. Neurol. 2010, 68, 477-493.
60. Steinman, L.; Zamvil, S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 2006, 60, 12-21.
61. Gao, X.; Kemper, A.; Popko B. Advanced transgenic and gene-targeting approaches. Neurochem. Res. 1999, 24, 1181-1188.
62. Wang, Y.; Ren, Z.; Tao, D.; Tilwalli, S.; Goswami, R.; Balabanov, R. STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells. Glia 2010, 58, 195-208.
63. Balabanov, R.; Stand, K.; Kemper, A.; Lee, J.Y.; Popko, B. Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma. J. Neurosci. 2006, 26, 5143-5152.
64. Agresti, C.; Bernardo, A.; Del Russo, N.; Marziali, G.; Battistini, A.; Aloisi, F.; Levi, G.; Coccia, E.M. Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-gamma and TNF-alpha in oligodendrocytes. Eur. J. Neurosci. 1998, 10, 2975-8293.
65. Stang, M.T.; Armstrong, M.J.; Watson, G.A.; Sung, K.Y.; Liu, Y.; Ren, B.; Yim, J.H. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells. Oncogene 2007, 26, 6420-6430.
66. Conte, E.; Manzella, L.; Zeuner, A.; Cocchiaro, G.; Conticello, C.; Zammataro, L.; Messina, C.G.; de Maria, R.; Messina, A. Involvement of interferon regulatory factor-1 in monocyte CD95 expression and CD95-mediated apoptosis. Cell Death Differ. 2003, 10, 615-617.
67. Tompkins, S.; Padilla, M.; Dal Canto, J.; Ting, J.; Van Kaer, L.; Miller, S. De novo Central Nervous System processing of myelin antigen is required for the initiation of Experimental Autoimmune Encephalomyelitis. J. Immunol. 2002, 168, 4173-4183.
68. Kassmann, C.M.; Lappe-Siefke, C.; Baes, M.; Brügger, B.; Mildner, A.; Werner, H.B.; Natt, O.; Michaelis, T.; Prinz, M.; Frahm, J.; et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 2007, 39, 969-976.
69. Bergsbaken, T.; Fink, L.; Cookson, B.T. Pyroptosis: Host cell death and inflammation. Nat. Rev. Microbiol. 2009, 7, 99-109.